Switch to: References

Add citations

You must login to add citations.
  1. Planning Ahead for Dementia Research Participation: Insights from a Survey of Older Australians and Implications for Ethics, Law and Practice.Nola Ries, Elise Mansfield & Rob Sanson-Fisher - 2019 - Journal of Bioethical Inquiry 16 (3):415-429.
    People with dementia have commonly been excluded from research. The adverse impacts of this exclusion are now being recognized and research literature, position statements, and ethics guidelines increasingly call for inclusion of people with dementia in research. However, few published studies investigate the views of potential participants on taking part in research should they experience dementia-related cognitive impairment. This cross-sectional survey examined the views of people aged sixty and older attending hospital outpatient clinics about clinical research participation if they had (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • The full spectrum of ethical issues in dementia research: findings of a systematic qualitative review.Tim G. Götzelmann, Daniel Strech & Hannes Kahrass - 2021 - BMC Medical Ethics 22 (1):1-11.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Challenges of anticipation of future decisions in dementia and dementia research.Julia Perry - 2022 - History and Philosophy of the Life Sciences 44 (4):1-29.
    Anticipation of future decisions can be important for individuals at risk for diseases to maintain autonomy over time. For future treatment and care decisions, advance care planning is accepted as a useful anticipation tool. As research with persons with dementia seems imperative to develop disease-modifying interventions, and with changing regulations regarding research participation in Germany, advance research directives (ARDs) are considered a solution to include persons with dementia in research in an ethically sound manner. However, little is known about what (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • The ethics of innovation for Alzheimer’s disease: the risk of overstating evidence for metabolic enhancement protocols.Timothy Daly, Ignacio Mastroleo, David Gorski & Stéphane Epelbaum - 2020 - Theoretical Medicine and Bioethics 41 (5):223-237.
    Medical practice is ideally based on robust, relevant research. However, the lack of disease-modifying treatments for Alzheimer’s disease has motivated “innovative practice” to improve patients’ well-being despite insufficient evidence for the regular use of such interventions in health systems treating millions of patients. Innovative or new non-validated practice poses at least three distinct ethical questions: first, about the responsible application of new non-validated practice to individual patients ; second, about the way in which data from new non-validated practice are communicated (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations